Natixis Investment Managers International Bristol Myers Squibb CO Transaction History

Natixis Investment Managers International

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$72.62 - $79.98 $3.59 Million - $3.95 Million	-49,448 Reduced 46.92%	55,939 $4.31 Million
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $6.48 Million - $7.77 Million	105,387 New	105,387 $7.7 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $4.26 Million - $5.53 Million	-87,452 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $2.41 Million - $2.72 Million	43,652 Added 99.66%	87,452 $5.43 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $1.14 Million - $1.42 Million	22,550 Added 106.12%	43,800 $2.42 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $1.27 Million - $1.47 Million	21,250 New	21,250 $1.34 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $911,747 - $994,038	-15,211 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$55.23 - $63.74 $54,401 - $62,783	-985 Reduced 6.08%	15,211 $970,000
Q2 2017 Aug 14, 2017	BUY	N/A	16,196	16,196 $902,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Natixis Investment Managers International, based on Form 13F filings with the SEC.

Stay updated on Natixis Investment Managers International with notifications on news.